Key result
ANGPTL4, ANGPTL3, and ANGPTL8 regulate lipoprotein lipase activity and compartmentalization by impacting its inherent protein instability at normal body temperature.
Why the study?
Increasing the longevity of LPL activity by attenuating inhibition from ANGPTL3, 4, and 8 is an emerging therapeutic strategy for lowering plasma triglycerides, warranting review of recent insights into ANGPTL regulation of LPL with emphasis on ANGPTL4.
Design
Mini-review
Loading...
No immediate clinical applications; leaves open whether ANGPTL-targeted therapies will improve outcomes in dyslipidemia.
Understanding the posttranslational regulation of LPL by ANGPTLs provides a molecular basis for emerging therapeutic strategies aimed at lowering plasma triglyceride levels.
A 2021 study conducted a review in Regulation of intravascular lipolysis. ANGPTL4 was evaluated. ANGPTL4, ANGPTL3, and ANGPTL8 regulate lipoprotein lipase activity and compartmentalization by impacting its inherent protein instability at normal body temperature.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: